Money Compass

Money Compass

Menarini Group Presents New Data from the Phase 1b/2 ELEVATE Study of Elacestrant in Combination with Capivasertib in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The efficacy data highlight how the combination of elacestrant and capivasertib has...

Read more
Page 65 of 2592 1 64 65 66 2,592

Welcome Back!

Login to your account below

Retrieve your password

Please enter your username or email address to reset your password.